Avanos Medical公司股价在2024年10月30日盘中出现重挫,一度下跌超18%,引发市场广泛关注。公司最新季度业绩数据或许是导致该股大跌的主要原因。
根据财报数据显示,Avanos Medical在截至9月30日的季度内,实现营收1.704亿美元,同比下滑0.5%;调整后每股收益为0.36美元,低于去年同期的0.42美元,也未能达到分析师平均0.35美元的预期。
对于业绩未达预期,分析人士指出,公司在美国等主要市场的销售增长乏力可能是主要原因。同时,Avanos Medical紧随行业巨头步伐,加大了在新兴市场的布局,但短期内营收贡献和利润率仍不及成熟市场。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.